The [URE3] prion in Candida

Eukaryotic Cell

Volumn 12, Issue 4, 2013, Pages 551-558

  Edskes, Herman K ^a   Wickner, Reed B Wickner ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; GLUTATHIONE PEROXIDASE;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CHEMISTRY; FUNGAL GENE; GENETIC COMPLEMENTATION; GENETICS; METABOLISM; PRION; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE; SACCHAROMYCES CEREVISIAE; SPECIES DIFFERENCE;

CANDIDA ALBICANS; CANDIDA GLABRATA; FUNGAL PROTEINS; GENES, MATING TYPE, FUNGAL; GENETIC COMPLEMENTATION TEST; GLUTATHIONE PEROXIDASE; PRIONS; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE; SPECIES SPECIFICITY;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; SACCHAROMYCES CEREVISIAE;

EID: 84874620417     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00015-13     Document Type: Article

References (56)

1. Magasanik B, Kaiser CA. 2002. Nitrogen regulation in Saccharomyces cerevisiae. Gene 290:1-18.
2. Cooper TG. 2002. Transmitting the signal of excess nitrogen in Saccharo-myces cerevisiae from the Tor proteinstothe GATA factors: connecting the dots. FEMS Microbiol. Rev. 26:223-238.
3. Wickner RB. 1994. [URE3] as an altered URE2 protein: evidence for a prion analog in S. cerevisiae. Science 264:566-569.
4. Masison DC, Wickner RB. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270: 93-95.
5. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. 1999. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283:1339-1343.
6. Brachmann A, Baxa U, Wickner RB. 2005. Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J. 24:3082-3092.
7. Shewmaker F, Mull L, Nakayashiki T, Masison DC, Wickner RB. 2007. Ure2p function is enhanced by its prion domain in Saccharomyces cerevi-siae. Genetics 176:1557-1565.
8. Baxa U, Taylor KL, Wall JS, Simon MN, Cheng N, Wickner RB, Steven A. 2003. Architecture of Ure2p prion filaments: the N-terminal domain forms a central core fiber. J. Biol. Chem. 278:43717-43727.
9. Masison DC, Maddelein Wickner M-LRB. 1997. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. Proc. Natl. Acad. Sci. U. S. A. 94:12503-12508.
10. Pierce MM, Baxa U, Steven AC, Bax A, Wickner RB. 2005. Is the prion domain of soluble Ure2p unstructured? Biochemistry 44:321-328.
11. Baxa U, Wickner RB, Steven AC, Anderson D, Marekov L, Yau Tycko W-MR. 2007. Characterization of β-sheet structure in Ure2p1-89 yeast prion fibrils by solid state nuclear magnetic resonance. Biochemistry 46: 13149-13162.
12. Edskes HK, Wickner RB. 2002. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein. Proc. Natl. Acad. Sci. U. S. A. 99(Suppl 4):16384-16391.
13. Baudin-Baillieu A, Fernandez-Bellot E, Reine F, Coissac E, Cullin C. 2003. Conservation of the prion properties of Ure2p through evolution. Mol. Biol. Cell 14:3449-3458.
14. Edskes HK, Engel A, McCann LM, Brachmann A, Tsai Wickner H-FRB. 2011. Prion-forming ability of Ure2 of yeasts is not evolutionarily conserved. Genetics 188:81-90.
15. Engel A, Shewmaker F, Edskes HK, Dyda F, Wickner RB. 2011. Amyloid of the Candida albicans Ure2p prion domain is infectious and has a parallel in-register β-sheet structure. Biochemistry 50:5971-5978.
16. Chernoff YO, Galkin AP, Lewitin E, Chernova TA, Newnam GP, Belenkiy SM. 2000. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol. Microbiol. 35:865-876.
17. Kushnirov VV, Kochneva-Pervukhova NV, Cechenova MB, Frolova NS, Ter-Avanesyan MD. 2000. Prion properties of the Sup35 protein of yeast Pichia methanolica. EMBO J. 19:324-331.
18. Santoso A, Chien P, Osherovich LZ, Weissman JS. 2000. Molecular basis of a yeast prion species barrier. Cell 100:277-288.
19. Nakayashiki T, Ebihara K, Bannai H, Nakamura Y. 2001. Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol. Cell 7:1121-1130.
20. Safadi RA, Talarek N, Jacques N, Aigle M. 2011. Yeast prions: could they be exaptations? The URE2/[URE3] system in Kluyveromyces lactis. FEMS Yeast Res. 11:151-153.
21. Talarek N, Maillet L, Cullin C, Aigle M. 2005. The [URE3] prion is not conserved among Saccharomyces species. Genetics 171:23-54.
22. Liebman SW, Chernoff YO. 2012. Prions in yeast. Genetics 191:1041-1072.
23. Schlumpberger M, Prusiner SB, Herskowitz I. 2001. Induction of distinct [URE3] yeast prion strains. Mol. Cell. Biol. 21:7035-7046.
24. Geitz RD, Woods RA. 2002. Transformation of yeast by the Liac/SS carrier DNA/PEG method. Methods Enzymol. 350:87-96.
25. Cormack BP, Falkow S. 1999. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 151:979-987.
26. Miyazaki H, Miyazaki Y, Gerber A, Parkinson T, Hitchcock C, Falconer DJ, Ward DJ, Marsden K, Bennett JE. 1998. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PHD1, in Candida glabrata. Antimicrob. Agents Chemother. 42:1695-1701.
27. Kaur R, Ma B, Cormack BP. 2007. A family of glycosylphosphatidyl-inositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc. Natl. Acad. Sci. U. S. A. 104:7628-7633.
28. ElBerry HM, Majumdar ML, Cunningham TS, Sumrada RA, Cooper TG. 1993. Regulation of the urea active transporter gene (DUR3) in Saccharomyces cerevisiae. J. Bacteriol. 175:4688-4698.
29. Uemura T, Kashiwagi K, Igarashi K. 2007. Polyamine uptake by DUR3 and SAM3 in Saccharomyces cerevisiae. J. Biol. Chem. 282:7733-7741.
30. Kakeya H, Miyazaki Y, Miyazaki H, Nyswaner K, Grimberg B, Bennett JE. 2000. Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob. Agents Chemother. 44:2985-2990.
31. Sikorski RS, Hieter P. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
32. Zhou P, Szczypka MS, Young R, Thiele DJ. 1994. A system for gene cloning and manipulation in the yeast Candida glabrata. Gene 142:135-140.
33. Hanic-Joyce PJ, Joyce PB. 1998. A high-copy-number ADE2-bearing plasmid for transformation of Candida glabrata. Gene 211:395-400.
34. Vernet T, Dignard D, Thomas DY. 1987. A family of yeast expression vectors containing the phage f1 intergenic region. Gene 52:225-233.
35. Edskes HK, Gray VT, Wickner RB. 1999. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc. Natl. Acad. Sci. U. S. A. 96:1498-1503.
36. Butler G, Kenny C, Fagan A, Kurischko C, Gaillardin C, Wolfe KH. 2004. Evolution of the MAT locus and its HO endonuclease in yeast species. Proc. Natl. Acad. Sci. U. S. A. 101:1632-1637.
37. Christianson TW, Sikorski RS, Dante M, Shero JH, Hieter P. 1992. Multifunctional yeast high-copy-number shuttle vectors. Gene 110:119-122.
38. Mitchell AP, Magasanik B. 1984. Regulation of glutamine-repressible gene products by the GLN3 function in Saccharomyces cerevisiae. Mol. Cell. Biol. 4:2758-2766.
39. Muller H, Hennequin C, Gallaud J, Dujon B, Fairhead C. 2008. The asexual yeast Candida glabrata maintains distinct a and a haploid mating types. Eukaryot. Cell 7:848-858.
40. Srikantha T, Lachke SA, Soll DR. 2003. Three mating type loci in Candida glabrata. Eukaryot. Cell 2:328-340.
41. Brockert PJ, Lachke SA, Srikantha T, Pujol C, Galask R, Soll DR. 2003. Phenotypic switching and mating type switching of Candida glabrata at sites of colonization. Infect. Immun. 71:7109-7118.
42. Brisse S, Pannier C, Angoulvant A, de Meeus T, Diancourt L, Faure O, Muller H, Peman J, Viviani MA, Grillot R, Dujon B, Fairhead C, Hennequin C. 2009. Uneven distribution of mating types among genotypes of Candida glabrata isolates from clinical samples. Eukaryot. Cell 8:287-295.
43. Zenthon JF, Ness F, Cox B, Tuite MF. 2006. The [PSI+] prion of Saccharomyces cerevisiae can be propagated by an Hsp104 orthologue from Candida albicans. Eukaryot. Cell 5:217-225.
44. Brachmann A, Toombs JA, Ross ED. 2006. Reporter assay systems for [URE3] detection and analysis. Methods 39:35-42.
45. Shorter J, Lindquist S. 2005. Prions as adaptive conduits of memory and inheritance. Nat. Rev. Genet. 6:435-450.
46. Harrison LB, Yu Z, Stajich JE, Dietrich FS, Harrison PM. 2007. Evolution of budding yeast prion-determinant sequences across diverse fungi. J. Mol. Biol. 368:273-282.
47. Ross ED, Baxa U, Wickner RB. 2004. Scrambled prion domains form prions and amyloid. Mol. Cell. Biol. 24:7206-7213.
48. Ross ED, Edskes HK, Terry MJ, Wickner RB. 2005. Primary sequence independence for prion formation. Proc. Natl. Acad. Sci. U. S. A. 102: 12825-12830.
49. Toombs JA, McCarty BR, Ross ED. 2010. Compositional determinants of prion formation in yeast. Mol. Cell. Biol. 30:319-332.
50. Vorberg I, Groschup MH, Pfaff E, Priola SA. 2003. Multiple amino acid residues within the rabbit PrP protein inhibit formation of its abnormal isoform. J. Virol. 77:2003-2009.
51. ter Schure EG, van Riel NA, Verrips CT. 2000. The role of ammonia metabolism in nitrogen catabolite repression in Saccharomyces cerevisiae. FEMS Microbiol. Rev. 24:67-83.
52. Hofman-Bang J. 1999. Nitrogen catabolite repression in Saccharomyces cerevisiae. Mol. Biotech. 12:35-71.
53. Rai R, Daugherty JR, Tate JJ, Buford TD, Cooper TG. 2004. Synergistic operation of four cis-acting elements mediate high level DAL5 transcription in Saccharomyces cerevisiae. FEMS Yeast Res. 5:29-41.
54. Stanbrough M, Magasanik B. 1995. Transcriptional and posttranscrip-tional regulation of the general amino acid permease of Saccharomyces cerevisiae. J. Bacteriol. 177:94-102.
55. Rubio-Texeira M, Kaiser CA. 2006. Amino acids regulate retrieval of the yeast general amino acid permease from the vacuolar targeting pathway. Mol. Biol. Cell 17:3031-3050.
56. Lacroute F. 1971. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol. 106:519-522.